Moderna’s COVID-19 Vaccine — What’s Next And Why Masks Will Still Be Needed

BOSTON — Moderna announced Monday it will send its COVID-19 vaccine to the Food and Drug Administration to get emergency use authorization.

From here, an FDA advisory panel made up of independent scientists and physicians will carefully review the data that has been submitted and then make a recommendation to the FDA which can either follow their recommendation or make its own determination.

In order to be granted emergency use authorization, the treatment, in this case a COVID-19 vaccine, will need to show that the known benefits clearly outweigh the known risks. This process usually takes up to a few weeks.

Read more at CBS Boston